Meluzio Michael Vincent — SEC insider filings

SEC reporting owner CIK 2138368. 3 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2026-07-10 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cue Biopharma, Inc. (CUE)VP, Prin. Accounting Officer3—4 legs · 6,772 sh · $201,4134

Insider filings — Meluzio Michael Vincent

FiledFormIssuerReported transactionsSource
2026-10-144Cue Biopharma, Inc. (CUE)Sale (S): 1,144 @ $28.05EDGAR
2026-08-174Cue Biopharma, Inc. (CUE)Option exercise (M): 13,647 @ $0 · Sale (S): 1,519 @ $29.37 · Sale (S): 4,106 @ $30.35 · Sale (S): 3 @ $31.13 · Option exercise (M): 13,647 (derivative) @ $0EDGAR
2026-07-104Cue Biopharma, Inc. (CUE)Grant/award (A): 40,942 @ $0 · Grant/award (A): 40,942 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2138368 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs